Radiolabeled FAPα inhibitors (68Ga-FAPI and 18F-FAPI) imaging by PET/CT have shown efficacy in labeling a wide range of solid carcinomas via interactions with cancer-associated fibroblasts [10,11], and may improve lesional localization and activity measurement in FD. This evidence concerns the gene FAP and cancer.